294 filings
Page 5 of 15
8-K
u4a84qls
26 May 21
Regulation FD Disclosure
8:34am
8-K
vg6ssrlxc7wvr wz2l15
20 May 21
Submission of Matters to a Vote of Security Holders
11:31am
8-K
xdzcyq5r4 a1doly3
25 Feb 21
Regulation FD Disclosure
12:00am
8-K
0nhot mnr2x0qh
17 Dec 20
Regulation FD Disclosure
9:31am
8-K
grh9uie lz54ou9
30 Sep 20
Verastem Oncology Announces Closing of COPIKTRA® (duvelisib) Sale to Secura Bio
9:03am
8-K
zre7eh
16 Sep 20
Verastem Oncology Announces Presentation of Updated Phase 1/2 FRAME Study Data at the 2nd Annual RAS-Targeted Drug Development Summit
8:47am
8-K
zuskfjhlmnw8 tltw60
13 Aug 20
Departure of Directors or Certain Officers
4:11pm
8-K
hj2jc5dfwnbuga dwj
10 Aug 20
Verastem Will Receive $70 Million Up-Front with Total Deal Value up to $311 Million, Plus Double-Digit Sales Royalties
8:30am
S-8
pw8j6cxmzna2v7bw
2 Jun 20
Registration of securities for employees
4:11pm
8-K
cm786xo vqtlsh9
21 May 20
Amendments to Articles of Incorporation or Bylaws
4:11pm
424B3
2kbga9rp1t 536a0et9
27 Apr 20
Prospectus supplement
1:42pm
8-K
pkh0i1
27 Apr 20
Results of Operations and Financial Condition
9:16am
8-K
2cohi 0zv06f
23 Apr 20
Verastem Oncology Appoints John H. Johnson to its Board of Directors
8:45am
DEFA14A
noi6ifw
21 Apr 20
Additional proxy soliciting materials
5:23pm